Main Subject
#1 in Business Subscribe Email Print

You are here: Home > Business > Venture Capital > Need Money? The Lowdown On Investors

Tags

  • doesnt
  • sophisticated
  • point
  • their money
  • developing combination

  • Links

  • Solar Panels and the IRS
  • Discount Flowers Online
  • A New Causation
  • Main Subject - Need Money? The Lowdown On Investors

    Everyone knows that equity capital and fast growth go hand-in-hand. Unfortunately outside investors drive hard bargains and the process seems to take forever. On top of that, you could get all the way to the end of the line to find out that either they don’t want you
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    or you don’t want them.

    What's going to gain favor for your business; is it a sound business plan, skin in the game or an operation that’s in the black but desperately needs a propeller? Once you locate investors that will give you the time of day the hard part beg
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ins. You’ll need the answers to questions such as:

    • How much are you willing to give up?

    • What else are you willing to do to see your company stay alive and thrive?

    • Just what is you company worth?

    The acceptable answer to these and other questions can vary fr
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    m one end of the spectrum to the other depending on whom and what type of investor you’re talking to. Think of potential investors like an inverse dart board. The bulls eye in this analogy is not the goal rather it’s the starting point and the ultimate objective is t
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    he big outer ring which represents the big money. The first fund-raising level is you. Your good name and credit are the first to go on the block. After all, if you don’t have the faith in yourself necessary to risk bankruptcy and homelessness then why should othe
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    people have faith in you?

    As you move to the next layer finding investors is still relatively easy but now you have to be willing to risk Mom and Dad’s retirement, and all that goes along with it, or hit on your friends and risk suffering their ridicule if things d
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    on’t work out.

    The better point of being here is that the value of the company, or its assets, are seldom in question. Most of the time these folks just want to help out because you’re either related or the benefactor of a great friendship. Their stock, if any is e
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    ver actually transferred, becomes a conversation piece or dream of future wealth. From a business stand point people in the inner circles will only bet on you once and rarely can you count on any of them for sound advice. The next circle is the angel investor. Thes
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    days finding an angel is fairly easy even if getting them to part with their money isn’t. Many of these folks accumulated their wealth by exercising stock options. That doesn’t necessarily make them wise business people and you still may have no where to go for good
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    , sound advice.

    Angels will sit down with you in a restaurant, at your expense, and talk to you about your business plan or model. If they get infected with your energy or enthusiasm and the model/plan is feasible you may get the backing you need. Angels aren’t espe
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    ially concerned about valuation but neither do they have large amounts of money.

    From here the going gets a little get tougher.

    The most common next layer is an incubator. Generally you get the basics, such as receptionists, assistants, meeting rooms, copy machines
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ; phone and network access is provided free or at a substantially reduced rate. If you find a good one you may receive help refining your business plan or, more importantly, you may get to network with, or receive council from, seasoned executives. The downside of
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    incubators is that some are government funded or assisted. In this case they may not be as experienced in the real worlds as you might like, they may be restricted or limited in the types of businesses and business models, and they expect a large part of your equity
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    n exchange for their services.

    If you decide to forgo incubators the next step is small venture and funds or angel groups. These funds consist of somewhat savvy people with an eye toward a certain market. Most often they aren’t chartered and sometimes their contribu
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    tors or members don’t meet the requirements for a sophisticated or accredited investor; reasonable intelligent individuals with net worth’s in excess of one million dollars.

    Some of these funds want a full blown business plan while others just want a one page execut
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ive summary. You’re asking for their money and to get it you’ll have to dance to their piper. They will also be more valuation oriented but the bottom line will be all over the place.

    You’re now in the big leagues but like any league the degree of “big” varies. The
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ttitude at this level is don’t call us, we’ll call you. You’ll rarely ever meet with anyone at this level without being referred by someone they trust or have done business with in the past.

    These companies rely on the financials when determining a potential busines
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    s's potential. They employee sophisticated analysts and they expect a certain rate of return. At this point a business plan alone won’t do. You will be expected to have a full-scale sales and marketing plan including a detailed profile of your customers and they’ll e
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    pect you to have customers and profits. You’ll also have to turn over a larger portion of your business in return for their cash, network and expertise especially the expertise.

    Along the way through the circles you’ll meet some very well meaning people and some not
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    so well meaning. Be aware of the fee for connecting folks. If you get involved, check credentials and references and make it understood, in no uncertain terms, that they can’t collect on promises and effort. Pay them only out of the proceeds that they secure for you


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.mainsubjects.org.ua/article/46615/mainsubjects-Need-Money-The-Lowdown-On-Investors.html">Need Money? The Lowdown On Investors</a>

    BB link (for phorums):
    [url=http://www.mainsubjects.org.ua/article/46615/mainsubjects-Need-Money-The-Lowdown-On-Investors.html]Need Money? The Lowdown On Investors[/url]

    Related Articles:

    Copywriting Technique For Web Business - Going Where The Money Is On The Web

    Funny Side to Outsourcing!

    Workplace Communication- What About Sarcasm?

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com